DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis

Por van Riel, Piet LCM, Fransen, Jaap
Publicado em 2005

Outcome measures in inflammatory rheumatic diseases

Por Fransen, Jaap, van Riel, Piet LCM
Publicado em 2009

FACTORS THAT INFLUENCE RHEUMATOLOGISTS’ DECISION TO ESCALATE CARE IN RA: RESULTS FROM A CHOICE BASED CONJOINT ANALYSIS

Por Kievit, Wietske, van Hulst, Laura, van Riel, Piet, Fraenkel, Liana
Publicado em 2010

Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare

Por Hendrikx, Jos, Fransen, Jaap, van Riel, Piet L C M
Publicado no RMD Open (2015)

Are patients' judgments of health status really different from the general population?

Por Krabbe, Paul FM, Tromp, Noor, Ruers, Theo JM, van Riel, Piet LCM
Publicado em 2011

Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data

Por Beretta Lorenzo, Santaniello Alessandro, van Riel Piet LCM, Coenen Marieke JH, Scorza Raffaella
Publicado em 2010-08-01

Time to achieve remission determines time to be in remission

Por Schipper, Lydia G, Fransen, Jaap, den Broeder, Alfons A, Van Riel, Piet LCM
Publicado em 2010

Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data

Por Beretta, Lorenzo, Santaniello, Alessandro, van Riel, Piet LCM, Coenen, Marieke JH, Scorza, Raffaella
Publicado em 2010

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals

Por Popa, Calin D., Arts, Elke, Fransen, Jaap, van Riel, Piet L. C. M.
Publicado em 2012

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis

Por Hendrikx, Jos, de Jonge, Marieke J, Fransen, Jaap, Kievit, Wietske, van Riel, Piet LCM
Publicado no RMD Open (2016)

High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sec...

Por Arts, Elke, Fransen, Jaap, Lemmers, Heidi, Stalenhoef, Anton, Joosten, Leo, van Riel, Piet, Popa, Calin D
Publicado em 2012

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy

Por Bhansing, Kavish J, Vonk-Noordegraaf, Anton, Oosterveer, Frank PT, van Riel, Piet LCM, Vonk, Madelon C
Publicado no RMD Open (2017)

What does the clinician need to improve patient care in systemic sclerosis?

Por Vonk, Madelon C, van den Hoogen, Frank H J, van Riel, Piet L C M, Valentini, Gabriele
Publicado em 2007

Evaluating quality of care in rheumatoid arthritis: the patient perspective

Por Mahmood, Sehrash, van Oosterhout, Marianne, de Jong, Sija, Landewé, Robert, van Riel, Piet, van Tuyl, Lilian H D
Publicado no RMD Open (2017)

Biosimilars in the management of chronic inflammatory diseases: The Dutch experience

Por Wieland D. Müskens, Rongen-van Dartel Sanne A. A., Eddy M. M. Adang, van Riel Piet L. C. M.
Publicado em 2019-01-01

Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology

Por Bhansing, Kavish J, Lammens, Martin, Knaapen, Hanneke KA, van Riel, Piet LCM, van Engelen, Baziel GM, Vonk, Madelon C
Publicado em 2014

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

Por Crowson, Cynthia S., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M., Gabriel, Sherine E., Semb, Anne Grete
Publicado no PLoS One (2017)

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

Por Crowson, Cynthia S., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M., Gabriel, Sherine E., Semb, Anne Grete
Publicado no PLoS One (2017)

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study

Por Flendrie, Marcel, Vissers, Wynand HPM, Creemers, Marjonne CW, de Jong, Elke MGJ, van de Kerkhof, Peter CM, van Riel, Piet LCM
Publicado em 2005

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

Por Siemons, Liseth, ten Klooster, Peter M, Vonkeman, Harald E, van Riel, Piet LCM, Glas, Cees AW, van de Laar, Mart AFJ
Publicado no BMC Musculoskelet Disord (2014)